cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2006; 47:1471-1477, doi:10.1016/j.jacc.2005.11.060 (Published online 14 March 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, G. D.
Right arrow Articles by Semigran, M. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lewis, G. D.
Right arrow Articles by Semigran, M. J.

Sildenafil Improves Coronary Artery Patency in a Canine Model of Platelet-Mediated Cyclic Coronary Occlusion After Thrombolysis

Gregory D. Lewis, MD*, Christian Witzke, MD*, Pedro Colon-Hernandez, MD*, J. Luis Guerrero*, Kenneth D. Bloch, MD*,{dagger} and Marc J. Semigran, MD*,*

* Cardiology Division
{dagger} Cardiovascular Research Center of the Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts


Figure 1
View larger version (16K):

[in a new window]
 
Figure 1 Schematic representation of the coronary artery patency status of 12 dogs during two sequential observation periods. All dogs were observed during an initial 60-min period (period 1). During the second period (period 2), six animals received sildenafil (50 µg/kg bolus followed by 4 µg/kg/min), whereas six control animals received no further treatment. White areas represent coronary patency (flow >25% of baseline), and black areas represent occlusion.

 

Figure 2
View larger version (10K):

[in a new window]
 
Figure 2 Coronary artery patency ratio (CAPR; fraction of an observed observation period during which the coronary flow was >25% of immediate postconstriction flow). Dogs in the control group (n = 6) were given no additional treatment in period 2. Dogs in the sildenafil group were given 100 µg/kg sildenafil bolus followed by an infusion of 4 µg/kg/min during period 2. *p = 0.008; #p = 0.007.

 

Figure 3
View larger version (9K):

[in a new window]
 
Figure 3 Effects of aspirin and sildenafil on platelet aggregation. (A) Thrombin-induced platelet aggregation during the treatment period (+aspirin [ASA], at 30 min, and +sildenafil and aspirin [S+ASA] at 90 min) relative to baseline aggregation in the pretreatment period, as determined by whole blood aggregometry (n = 6 dogs). *p < 0.05, ASA versus baseline. *#p < 0.05, ASA+sildenafil versus each of the other groups. (B) Representative platelet aggregation recordings in dog 9.

 

Figure 4
View larger version (9K):

[in a new window]
 
Figure 4 Effect of the bolus administration of sildenafil on mean arterial blood pressure (MAP). There was a transient fall in MAP within 1 min of the bolus administration of sildenafil that persisted for 3 min. The MAP 5 min after sildenafil administration did not differ from that at the end of period 1. *p < 0.05.

 




 
  cardiology careers collections past issues search home